Reasons to Retain DexCom (DXCM) Stock in Your Portfolio for Now

DexCom, Inc. (DXCM) is well poised for growth in the coming quarters, backed by its strong product portfolio. A robust third-quarter 2023 performance, along with a series of favorable coverage decisions, is expected to contribute further. However, risks related to stiff competition persist.This currently Zacks Rank #3 (Hold) company’s shares have risen 19.9% in the past year against the industry’s 0.2% decline. The S&P 500 Index has increased 22.2% in the same time frame.DXCM, a renowned medical device comp ...